Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Liraglutide and BAC Water Mix

Liraglutide Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Liraglutide Titration Schedule

PhaseTimelineDaily DoseFrequency / Route
InitiationWeek 10.6 mg1× daily (SC)
TitrationWeek 21.2 mg1× daily (SC)
Maximum (Victoza)As needed1.8 mg1× daily (SC)
Titration (Saxenda)Week 42.4 mg1× daily (SC)
Target (Saxenda)Week 5+3.0 mg1× daily (SC)

FDA-approved (Victoza for T2D, Saxenda for weight loss). Saxenda continues to 3.0 mg; Victoza maximum is 1.8 mg.

Possible vial strengths:

What Is It?

Liraglutide

Daily GLP-1 analogue, predecessor to semaglutide.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Liraglutide

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Liraglutide Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Daily — and this is the biggest difference from semaglutide or tirzepatide. Liraglutide is injected once every day, so a vial empties far faster than a weekly peptide. If the calculator shows "7 doses per vial," that's 7 days for liraglutide, not 7 weeks. Keep that in mind when planning how much a single vial covers.
It titrates daily, not weekly: 0.6 mg for the first week, then 1.2 mg, with 1.8 mg as the typical maximum for the diabetes product (Victoza). Each step gives the body time to adjust and limits nausea. In the calculator, remember every figure is a once-daily dose, so plan vial use day by day.
The approved pen is fixed at 6 mg/mL, where 0.6 mg = 10 units and 1.2 mg = 20 units on a U-100 syringe. Compounded or research-grade powder has no fixed concentration — you set it by how much BAC water you add, so the units per dose depend on your mix. Reconstitute a 10 mg vial with ~1.7 mL to land near 6 mg/mL and the unit math matches the pen.
The approved weight-management product (Saxenda) titrates daily: 0.6 mg in week 1, then +0.6 mg each week — 1.2 → 1.8 → 2.4 → 3.0 mg — reaching a 3.0 mg daily maintenance dose. The diabetes product (Victoza) tops out lower, around 1.8 mg daily. These figures mirror the approved medicines and are shown for reference, not as a recommendation — dose decisions belong with a licensed clinician.
YYes. Store reconstituted solution at 2–8°C (36–46°F), protected from light, and keep sealed powder coldest in the freezer (−20°C) for long-term storage. Avoid heat and repeated freeze-thaw cycles, which degrade the peptide.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides